Anzeige
Mehr »
Montag, 07.07.2025 - Börsentäglich über 12.000 News
EchoIQ von 3 Analysehäusern als "Best-in-Class" bewertet - Kurszielpotenzial von über 200?%
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
379 Leser
Artikel bewerten:
(0)

EQS-News: Report on CPH Chemie + Papier Holding AG by Research Dynamics: HY2019 earnings update

EQS Group-News: Research Dynamics / Key word(s): Research Update 
Report on CPH: HY2019 earnings update 
 
2019-07-22 / 07:30 
 
This report is published by Research Dynamics, an independent research 
boutique 
 
*Execution on track despite macroeconomic challenges* 
 
*Healthy 1H2019 results, with all time high EBIT margins* 
CPH reported an encouraging set of numbers across segments with top line 
increasing by 1.3% YoY to CHF 267.5mn (2.1% YoY ex-currency), despite 
challenging economic conditions including the US and China trade war, and 
uncertainties related to Brexit. The overall growth reflected higher 
capacity utilisation and sales price increase with largely stable cost 
(fixed and variable) across divisions. Group EBIT improved significantly to 
CHF 32.0mn from CHF 27.8mn in 1H/18, posting highest ever EBIT margin of 
12.0%, since CPH's listing in 2011, compared to 10.5% in the same period 
last year. The net profit reported at CHF 27.2mn increased by 20.1% YoY (CHF 
22.6mn in 1H/18) with corresponding margin improving by 160bps to 10.2%. 
Although, all divisions reported positive EBIT for the period, Paper 
division in particular led the increase in group EBIT, as favourable 
supply-demand situation allowed further price increase. The Paper division 
reported EBIT of CHF 19.0mn, significantly higher compared to CHF 14.8mn in 
1H2018, and corresponding margin improved to 12.9% from 10.0% during the 
same period last year. 
 
*Segmental performance* 
 
*Paper:* The Paper Division reported a slight decline in sales, which 
dropped 0.8% YoY (-0.6% YoY ex-currency) to CHF 146.9mn. The primary reason 
for the decline at the top line is the continued structural erosion in the 
demand for such paper products. Various paper manufacturers have cut their 
production of magazine paper totalling to 750k tonnes, which should have a 
positive impact on the prices going forward. According to the company, 
supply-demand for newsprint and magazine paper was virtually similar at the 
beginning of the year, which allowed the company to increase some paper 
prices in early 2019. The divisional EBIT increased significantly by 28.0% 
YoY to CHF 19.0mn from CHF 14.8mn in 1H/18 and the corresponding margin 
improved to 12.9% (1H/18:10.0%). The improvement in EBIT margin reflects 
improved productivity and reduction in cost due to the successful 
integration of the paper recovery activities of Papierfabrik Utzenstorf, 
thanks to which more recycled paper can be sourced from Switzerland itself, 
directly reducing overall transportation costs of the division. 
 
*Packaging:* Despite the weak growth in pharmaceuticals in the first half of 
the fiscal, the net sales at the Packaging Division increased by 2.8% YoY 
(5.9% YoY ex-currency) to a record high of CHF 80.8mn from CHF 78.7mn. 
Although, the overall packaging market was down during the first half of 
2019 but the company's strategic initiatives are starting to bear fruits, 
e.g., the Suzhou plant has obtained the product licences from the local 
Chinese regulators. In addition, the new finishing and logistics centre in 
Brazil is operational since last autumn. Divisional EBIT improved to CHF 
10.1mn from CHF 9.6 and corresponding EBIT margin also improved slightly by 
20bps to 12.4%. Despite the increased raw material cost, EBIT margin 
improved due to better product mix of high-value products. 
 
*Chemistry:* The Chemistry Division reported an increase of 6.3% YoY (4.9% 
YoY ex-currency) in net sales to CHF 39.7mn in 1H/19. The increase in top 
line was driven by better utilization of manufacturing facilities along with 
higher demand for molecular sieves. In addition, the company completed its 
repositioning of the Chemistry Division and also expanded its marketing and 
distribution network in Brazil, Bahrain and Czech Republic. The segment 
reported 10.5% decrease in EBIT to CHF 3.1mn with the corresponding margin 
narrowed to 7.8% from 9.2% in 1H/18 due to higher other operating income 
during 1H/18. 
 
*Full-year guidance maintained* 
In spite of decent performance during the first half, management is 
skeptical about full year 2019 due to various macroeconomic uncertainties. 
The Group expects slowdown in global economic activities for the fiscal 2019 
and reaffirms its guidance issued at the beginning of the year. The guidance 
provided assumes broadly stable currency rates during 2H/19. The group 
expects to report full-year net sales, EBIT margin and net profit results 
for 2019 at around prior-year levels. 
 
*Paper:* The company expects additional pressure on paper prices as the 
demand for newspaper and magazine paper is expected to decline further 
during the second half of the year due to existing overcapacities in the 
market. Management expects net sales and EBIT margin to remain in-line with 
the previous year and is keen to keep up the efforts to enhance efficiency 
and reduce costs further. 
 
*Packaging:* The current trade war between the US and China along with other 
economic challenges increases the uncertainty in the business environment 
and its impact on the pharma markets. The company expects to report a slight 
increase or similar level of net sales as well as EBIT margin for the full 
year as compared to the previous year. 
 
*Chemistry:* Although the current business environment is challenging, 
management expects stable utilization of production facilities based on 
healthy order book. The company expects net sales and EBIT margin at similar 
levels compared to 2018. 
 
*Estimate change* 
The reported result is encouraging given the global business uncertainty. 
For the second half of the year, the company expects a slowdown compared to 
1H/19. We have increased our estimates slightly based on the first half 
results. Although, we have kept our revenue estimates unchanged, considering 
improved cost structure at the Paper Division and high end product mix at 
the Chemistry and Packaging Division along with one time other operating 
income, we have raised our EBIDTA estimates to CHF 83.5mn from CHF 81.5mn 
(earlier estimates). Consequently, the net earnings is expected to be around 
CHF 43.2mn compared to CHF 39.0mn estimated previously. 
 
*Refinancing to reduce financial burden* 
On 10th July 2019, the company repaid its CHF 120mn bond with 2.75% coupon. 
The repayment was done by new bond issue along with cash at hand. On 8th Oct 
2018, the company issued at par corporate bonds worth CHF 100mn with a 
maturity of 5 years with an annual coupon rate of 2.0% to repay the 
aforementioned bond. Due to the repayment of the CHF 120mn bond, total debt 
decreased by CHF 20mn and total balance sheet by CHF 120mn. In addition, the 
equity ratio increased towards 60% due to reduction in debt (total assets). 
Further, to increase credit flexibility, the company arranged a new 
additional line of credit with Swiss banks of CHF 40mn. 
 
*Valuation and conclusion* 
We value CPH using DCF and relative valuation techniques. Our intrinsic 
value of CHF 102.7 per share is marginally higher to our previous target 
price (CHF 100.6), implying an upside of 20.8% from current levels. For 
relative valuation, since the Group operates in three entirely different 
divisions, we compare each of CPH's divisions with different sets of 
relevant industry peers. We have employed three parameters - EV/EBITDA, P/S 
and P/E - to analyse the relative valuation of the Group. CPH currently 
trades at a P/S multiple of 0.9x (FY2019E), a significant 44% discount to 
the weighted average multiple of division's peers. 
 
In the medium-term, we expect this discount to narrow and the stock to 
witness a re-rating, considering strong growth prospects in key markets, 
improved operating efficiencies from the new production facilities and 
expansion of its Packaging and Chemistry divisions. The Paper Division 
should benefit from the consolidation and production cut coupled with cost 
saving initiatives, advanced technology and continued operational 
improvements. Nevertheless, the business environment with decreasing demand 
for newsprint paper remains challenging. However, continuing effort to 
diversify the company itself from a paper manufacturer to a conglomerate 
should stabilize the revenue stream going forward. 
 
Additional features: 
 
Document: http://n.eqs.com/c/fncls.ssp?u=AJACUUWJQC [1] 
Document title: CPHN_HY19 Results_Research Dynamics_22.7.2019 
 
End of Corporate News 
844425 2019-07-22 
 
 
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=5edc2a6d120570800b8ad1afc402a4fb&application_id=844425&site_id=vwd&application_name=news 
 

(END) Dow Jones Newswires

July 22, 2019 01:30 ET (05:30 GMT)

© 2019 Dow Jones News
Hensoldt, Renk & Rheinmetall teuer
Rheinmetall, Renk und Hensoldt haben den Rüstungsboom der letzten Jahre dominiert, doch inzwischen sind diese Titel fundamental heillos überbewertet. KGVs jenseits der 60, KUVs über 4, und das in einem politisch fragilen Umfeld mit wackelnder Haushaltsdisziplin. Für späteinsteigende Anleger kann das teuer werden.

Doch es gibt Alternativen, die bislang unter dem Radar fliegen; solide bewertet, operativ stark und mit Nachholpotenzial.

In unserem kostenlosen Report zeigen wir dir, welche 3 Rüstungsunternehmen noch Potenzial haben und wie du von der zweiten Welle der Zeitenwende profitieren kannst, ohne sich an überhitzten Highflyer zu verbrennen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders vom weltweiten Aufrüsten profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.